{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2016", "item": "https://www.patentleaderboard.com/2016/"}, {"@type": "ListItem", "position": 3, "name": "Amgen", "item": "https://www.patentleaderboard.com/2016/company/amgen"}, {"@type": "ListItem", "position": 4, "name": "Daniel La", "item": "https://www.patentleaderboard.com/2016/inventor/fl:da_ln:la-1"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
DL

Daniel La — 2 Patents in 2016

AMAmgen: 2 patents #61 of 377Top 20%
East Sharon, MA: #8 of 15 inventorsTop 55%
Massachusetts: #2,120 of 12,163 inventorsTop 20%
Overall (2016): #149,492 of 481,213Top 35%
2 Patents 2016

Issued Patents 2016

Showing 1–2 of 2 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
9458152 Bicyclic sulfonamide compounds as sodium channel inhibitors Matthew Weiss, Alessandro Boezio, Christiane Boezio, John R. BUTLER, Margaret Chu-Moyer +12 more 2016-10-04 $255,050,000
9346798 Dihydrobenzoxazine and tetrahydroquinoxaline sodium channel inhibitors Christiane Boezio, Alessandro Boezio, Howard Bregman, Nagasree Chakka, James R. Coats +8 more 2016-05-24 $192,745,000